RSS

biopharmaceutical

Biopharmaceutical analytical and bioanalytical contract solutions provider, SGS, has revealed it is investing more than $1.7 million to expand its North American biopharmaceutical testing capabilities in Illinois. more

News

Global biopharmaceutical outsourcing services provider, PCI Pharma Services, has acquired California-based Sherpa Clinical Packaging — a provider of clinical trial supply services. more

News

Inoviem Scientific, a contract research biotech, has entered into a service-based partnership with XoNovo, a preclinical-stage biopharmaceutical company that is developing a proprietary small molecule for the treatment of neurodegenerative diseases more

News

Preclinical stage drug discovery company, CYTOO, and biopharmaceutical company, Pfizer, have announced a research collaboration with the aim of developing a target discovery platform for Duchenne Muscular Dystrophy (DMD). more

News

Polyphor — a clinical stage Swiss biopharmaceutical company — has raised CHF 6.8 million from the Novo REPAIR Impact Fund to accelerate the development of novel antibiotics against multi-drug resistant Gram-negative pathogens. more

News

Biopharmaceutical company, Secarna Pharmaceuticals, has entered into a co-development agreement with research and development company, Firebrand Therapeutics, for novel cancer therapies. more

News

Global biopharmaceutical company, Sanofi, has reached a civil settlement with the US Securities and Exchange Commission (SEC), leading to a full resolution of the commission’s investigation into the company more

News

Biopharmaceutical analytical and bioanalytical contract solutions provider, SGS, has revealed it is expanding its biopharmaceutical testing capabilities in Geneva, Switzerland with a new 200 m2 lab. more

News

Sartorius, an international partner of the biopharmaceutical industry and research sector, has set up an independent Life Science Factory aimed at promoting start-ups and attracting entrepreneurs from the life science sector. more

News

In order to boost the commercialisation of new technologies and support manufacturing capabilities in the life sciences sector, the Swedish government and GE Healthcare are opening an innovation centre — Testa Center. more

News

Biopharmaceutical solutions organisation, Syneos Health, has acquired an advisory and operational solutions provider to the global life sciences industry, Kinapse, to enhance its end-to-end capabilities. more

News

Clinical-stage biopharmaceutical company, ASLAN Pharmaceuticals, has been granted orphan drug designation (ODD) for its treatment for acute myeloid leukaemia (AML) — ASLAN003 — by the US Food and Drug Administration (FDA). more

News

Clinical-stage biopharmaceutical company, Motif Bio, has received acceptance from the US Food and Drug Administration (FDA) for the filing of its new drug application (NDA) for iclaprim to treat acute bacterial skin and skin structure infections more

News

A subsidiary of WuXi AppTec, STA Pharmaceutical, has announced a strategic partnership with biopharmaceutical company, Antengene, for the CMC development and manufacturing of innovative oncology drugs. more

News

A co-development agreement has been formed by Xbrane Biopharma and STADA Arzeneimittel for the development of Xlucane — a biosimilar to Lucentis (ranibizumab), which is mainly used for the treatment of wet age-related macular degeneration (AMD). more

News

Clinical-stage biopharmaceutical company, Immatics Biotechnologies, has entered into a research collaboration and licence agreement with international biotech company, Genmab, to develop next generation bispecific cancer immunotherapies. more

News

Biopharmaceutical company, NBE Therapeutics, has closed an extension of its Series B financing round with CHF 20 million investment from Novo Holdings, making it a major shareholder. more

News

PhoreMost, UK-based biopharmaceutical company, has entered into a collaboration with o2h discovery (o2h) — an Anglo-Indian medicinal chemistry company that has in-house capability to take drug discovery programmes to the IND filing stage. more

News

Artelo Biosciences, a biopharmaceutical company, has entered into a global research and development partnership with India-based integrated discovery-development service provider, Syngene, and UK-based specialist CRO, Aptus Clinical. more

News

Biopharmaceutical company, InflaRx, has opened a new research facility in Ann Arbor, Michigan, USA, to further develop and extend the company’s complement system-based therapeutics. more

News